View Post

Researchers reveal distinct molecular signature in tumor tissues of Black breast cancer patients

In In The News by Barbara Jacoby

Source: Roswell Park Comprehensive Cancer Center From: news-medical.net A Roswell Park Comprehensive Cancer Center team led by Christine Ambrosone, PhD, and Song Yao, PhD, has revealed a distinct molecular signature in the tumor tissues of Black patients with breast cancer. The new work, published today in JNCI, the Journal of the National Cancer Institute, reports that an elevated number of …

View Post

New Study Suggests Role for Hormone Therapy to Treat Even Small, T1a Breast Cancers

In In The News by Barbara Jacoby

By: Roswell Park Comprehensive Cancer Center From: newswise.com Patients with tumors under 0.5 cm have not been widely offered this treatment previously Largest known study on hormone therapy for patients with small breast tumors Analysis reveals survival benefit for patients who had endocrine therapy Hormone therapy should be discussed with these patients as treatment option Many people diagnosed with breast …

View Post

Supplement Use Before, During Chemo Could Up Risk for Recurrence

In Uncategorized by Barbara Jacoby

From: clinicaloncology.com Breast cancer patients who use certain supplements before and during chemotherapy are more likely to experience disease recurrence and related death than those who do not use supplements, according to data from more than 1,100 patients. Lead researcher Christine Ambrosone, PhD, the chair of the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center, in …

View Post

New clinical trials at Roswell Park build on virus research for innovative immunotherapy approach

In Clinical Trials by Barbara Jacoby

By: Katie Alexander From: www.wivb.com The Roswell Park Comprehensive Cancer Center is once again on the cutting-edge of research to find new cures, and Western New Yorkers could play a big role as clinical trials open for an innovative new approach to immunotherapy. Over the decades, there has been a lot of progress for certain types of cancers with immunotherapies, …